Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
Deutsche Bank $1.5 billion subordinated Tier 2 notes offering
The 7.079% notes are due 2033
RxSight $50 million follow-on offering
The stock is listed on the Nasdaq Global Market
Xponential Fitness $122.5 million secondary offering
We advised Xponential Fitness on the offering
Comcast $1 billion inaugural green bond offering
We advised Comcast on the investment-grade debt offering
Elevance Health $2.6 billion senior notes offering
The investment-grade notes are due 2026, 2033 and 2053
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Central American Bank for Economic Integration $1.25 billion social notes
The 5.000% senior notes are due 2026
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
IBM $3.25 billion, €4.25 billion and £750 million notes offering
The investment-grade debt consists of nine tranches of notes